EO 14398
Active Awarded Last action
- Contract number
- 75N93023D00004
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $20,168 obligated
Award facts
- Opportunity
-
- Resources to advance pediatrics and HIV prevention science Pre-Solicitation · 75N93021R00020 · Posted Feb 18, 2022
- Combined order value
- $20,168 Current and potential, with all options
- Last date to order 50% complete
- IDV ceiling <1% used
- $98,878,757.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Lovelace Biomedical Research Institute with a ceiling of $98,878,757 on April 15, 2023, as a multiple-award vehicle under the Resources to Advance Pediatrics and HIV Prevention Science program. The contract carries no set-aside designation and extends through April 14, 2030.
Performance takes place in Albuquerque, New Mexico. The originating pre-solicitation, posted February 18, 2022, sought multiple IDIQs to provide preclinical development support services for HIV, pediatric, and prevention products, including preclinical gap filling, animal model studies, bioanalytical support, product manufacturing, and scientific and quality support services. The government anticipated issuing approximately two annual task orders each for preclinical and animal model services and bioanalytical and manufacturing support, and four task orders annually for scientific and quality services.
A delivery order issued under this IDIQ on April 15, 2023, obligated $20,168 for guaranteed minimum work to develop a quality assurance and quality control plan and participate in a task order initiation meeting. The delivery order ran from April 2023 through June 2024 under a cost-no-fee structure, supporting the Institute's pediatric health and HIV/AIDS prevention research programs.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Guaranteed minimum | National Institute of Allergy and Infectious Diseases (NIH) | $20,168 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93023D00004?
75N93023D00004 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2023.
How much is contract 75N93023D00004 worth?
Orders under 75N93023D00004 have obligated $20,168. 75N93023D00004's own ceiling is $98,878,757.
How many orders have been placed under contract 75N93023D00004?
1 order has been placed under 75N93023D00004, the latest on April 15, 2023.
Who can order from contract 75N93023D00004?
75N93023D00004 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93023D00004 part of a contract vehicle?
Yes. 75N93023D00004 is part of Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93023D00004 competed?
The extent of competition for 75N93023D00004 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV